Home › Funds › TUCKER ASSET MANAGEMENT LLC › AMRX

TUCKER ASSET MANAGEMENT LLC position in AMRX

AMNEAL PHARMACEUTICALS INC · Health Care

TUCKER ASSET MANAGEMENT LLC reported holding 511,064 shares of AMRX (AMNEAL PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$10.3M, representing 2.54% of its reported portfolio and ranking #6 among its reported holdings. TUCKER ASSET MANAGEMENT LLC has disclosed AMRX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

Latest position (Q3 2026)511.06K sh
Reported value held$10.29M
Portfolio Weight2.54%
First reportedQ2 2024
Last changeReduce
Updated2026-11-13

Last updated: 2026-11-13 · Source: SEC EDGAR Form 13F-HR

How TUCKER ASSET MANAGEMENT LLC's AMRX position evolved

TUCKER ASSET MANAGEMENT LLC first disclosed a stake in AMRX in Q2 2024 at 1,111,064 shares (US$7.1M). The position peaked in Q2 2026 at 1,011,064 shares, worth US$17.5M. Across 10 filings, TUCKER ASSET MANAGEMENT LLC increased the stake 0 time(s), trimmed it 2 time(s) and left it unchanged 7 time(s). The most recent filing (Q3 2026) shows 511,064 shares valued at US$10.3M — a reduction of -500,000 shares quarter over quarter.. Notable position changes include a 49% trim in Q3 2026 (shares rose 6% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 1.11M $7.06M New
Q3 2024 1.11M $9.24M Hold
Q4 2024 1.11M $8.80M Hold
Q1 2025 1.11M $9.31M Hold
Q2 2025 1.11M $8.99M Hold
Q3 2025 1.11M $11.12M Hold
Q4 2025 1.01M $12.74M Reduce
Q1 2026 1.01M $12.57M Hold
Q2 2026 1.01M $17.50M Hold
Q3 2026 511.06K $10.29M Reduce

Dots on the line are colored by change type; missing quarters mean no position was reported.

About AMRX and 13F data

AMRX (AMNEAL PHARMACEUTICALS INC) is a Health Care company. 45 other funds we track also report a position in AMRX — the largest reported positions include TPG GP A, LLC (US$213.4M), Rubric Capital Management LP (US$176.0M), Nantahala Capital Management, LLC (US$39.3M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding AMRX

All AMRX fund holders →

FAQ

How long has TUCKER ASSET MANAGEMENT LLC held AMRX?

TUCKER ASSET MANAGEMENT LLC has disclosed AMRX holdings in 10 of the last 10 reported quarters, going back to Q2 2024.

What is TUCKER ASSET MANAGEMENT LLC's current position in AMRX?

As of Q3 2026, TUCKER ASSET MANAGEMENT LLC holds 511.06K shares of AMRX (AMNEAL PHARMACEUTICALS INC), valued at $10.29M, representing 2.54% of its reported portfolio and ranking #6.

Has TUCKER ASSET MANAGEMENT LLC been buying or selling AMRX?

In the latest 13F filing (Q3 2026), TUCKER ASSET MANAGEMENT LLC reduced its position in AMRX. The position peaked in Q2 2026 at 1.01M shares.

Which other funds hold AMRX?

Other major institutional holders of AMRX include TPG GP A, LLC, Rubric Capital Management LP, Nantahala Capital Management, LLC, among 45 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.